Page results
-
Our clinical work includes thoracic surgery, obstetrics, inpatient and day-case surgery, chronic and acute pain, pre-assessment and exercise testing, imaging, endoscopy and radiotherapy.
-
Digital accessibility and sustainability drive a switch to online patient information at UCLH
-
You can use MyCare on your mobile, tablet or computer to securely view and manage information about your health and care at UCLH.
-
The rhinology unit covers all aspects of nose and sinus disease including allergy, infection, inflammatory/mucosal conditions, breathing disorders and tumours.
-
The Dermatology Department at University College Hospital is located in the Mortimer Market Centre and is housed in a newly refurbished dedicated skin clinic area where we see all of our adult patients for their outpatient appointments as well as surgical procedures and phototherapy.
-
The FGM service provides consultations, assessments, and support and referral to other services where clinically indicated
-
Online form for beginning the sefl referral process at UCLH maternity services.
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
Radiotherapy Department Patient Information series no. 18 - prostate brachytherapy prostate high dose rate (HDR) brachytherapy
-
This page provides an overview of the Ambulatory Care Service for adult patients.
File results
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0395 - Treatment and services for duchenne muscular dystrophy